following the merger of Fujisawa Pharmaceutical and Yamanouchi Pharmaceuticals and ranks in the top 20 global pharmaceutical companies in sales.
Fujisawa created the first Japanese pharmaceutical company in Canada by acquiring Lyphomed Canada in the early nineties and becoming Fujisawa Canada.
Thanks to Yamanouchi’s rich product pipeline, Astellas has introduced new products since the merger and looks forward to future growth in several therapeutic categories.
This “Flying Star” brand mark reflects the corporate vision of Astellas – to deliver hope and happiness to all for a healthy life, supported by state-of-the-art science, technology and new insights.
The red colour represents an enriched and healthy lifestyle while the gray text expresses credibility in state-of-the-art science and technology.